Skip to main content
. 2016 Jan-Mar;8(1):47–51. doi: 10.4103/0975-7406.171695

Table 2.

Response of the doctors on frequency of interaction with MRs of pharmaceutical companies?

graphic file with name JPBS-8-47-g002.jpg